Golden Biotechnology Corporation, established by Mr. Sheng Yung, Liu in 2002, is a preeminent and pioneering company specialized in drug discovery and evidence-based nutritional supplement production with a commitment to improving lives through the development of high-quality products for disease prevention and treatment. GBC’s primary emphasis is on novel drug research and development, intellectual property rights, pharmacology, toxicology, and clinical trials. Additionally, GBC has effectively established screening platforms to identify biologically active compounds from traditional Chinese herbal medicine, encompassing over 480 varieties of local plants, 1300 species of fungi, mushrooms, and seaweeds.